Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 20, 2026
TickeronGET DAILY SIGNALS
ACMR vs ICHR: Weighing Semiconductor Equipment Plays in the AI Investment Cycle

ACMR vs ICHR: Weighing Semiconductor Equipment Plays in the AI Investment Cycle

Key Takeaways

  • Both ACMR and ICHR are semiconductor-equipment suppliers riding the artificial intelligence (AI) chip-investment cycle, yet they occupy different parts of the value chain.
  • ACMR combines stronger top-line growth, a record order backlog, and a net-cash balance sheet, but carries concentrated exposure to China.
  • ICHR is executing a sharper profitability turnaround and margin expansion, though cash conversion and working-capital build remain open questions.
  • Both stocks sold off sharply in recent weeks on sector-wide AI-spending fears, creating meaningful valuation resets across semiconductor equipment names.
  • Tickeron AI Verdict: Based on trend consistency, backlog visibility, balance-sheet stability, and relative positioning, the AI framework currently favors ACMR over ICHR.

Introduction

Semiconductor equipment makers sit at the center of the ongoing AI infrastructure buildout, and both ACMR and ICHR have drawn intense investor interest as a result. Although both serve chip manufacturers, they address different stages of production, which shapes their growth profiles, margin dynamics, and risk exposures. This comparison examines how the two companies stack up on business model, recent momentum, financial strength, and market positioning. Growth-oriented technology investors, semiconductor-sector specialists, and traders assessing relative performance after a sharp sector-wide pullback may find the contrast particularly useful.

ACMR Overview and Recent Performance

ACMR, ACM Research, Inc., designs and manufactures specialized semiconductor process equipment, including wafer-cleaning systems, electrochemical plating, furnaces, and advanced-packaging tools. Based in Fremont, California, it generates a substantial share of its revenue from China, where it holds a strong position in the wafer-cleaning segment. Recent market activity has been volatile: the stock fell roughly 65% from its 52-week high amid a broader semiconductor-equipment selloff tied to fears that AI capital spending could slow, even as the company's own demand signals strengthened. In its latest quarter, revenue grew about 37% year over year, and management raised its full-year revenue outlook to a range of $1.24 billion to $1.28 billion. A record backlog of roughly $2.5 billion, up about 88% year over year, underpins that guidance, while the company also maintains a sizable net-cash position. China concentration and execution on margin targets remain key watch points. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

ICHR Overview and Recent Performance

ICHR, Ichor Holdings, Ltd., designs and manufactures critical fluid-delivery subsystems and components for semiconductor capital equipment, including gas and chemical delivery systems used in etch, deposition, and cleaning processes. The company has been executing a multi-quarter profitability turnaround, with recent quarterly revenue rising about 37% year over year and non-GAAP earnings beating consensus. Gross margin expanded meaningfully as proprietary content within its gas systems climbed above 30%, with management targeting roughly 35% by year-end. Despite this operational progress, the stock has pulled back sharply in recent weeks alongside the wider sector, and questions around cash generation persist, as rising inventory and receivables have kept free cash flow negative. A higher valuation multiple, capacity investments in Malaysia and Mexico, and supply-chain constraints in components such as flow controllers are among the factors shaping sentiment.

Head-to-Head Comparison

The two companies represent different bets on the same industry. ACMR is primarily a tool maker with heavy exposure to China's chip-manufacturing expansion and advanced packaging, giving it strong cyclical growth but also geopolitical and customer-concentration risk. ICHR is a subsystems and components supplier whose turnaround depends on internal manufacturing execution, margin expansion, and rising proprietary content rather than pure volume growth alone. On financial stability, ACMR holds a net-cash position and a record backlog, while ICHR is investing heavily in working capital and capacity, which pressures near-term cash flow. In terms of market positioning, ACMR trades at a more moderate earnings multiple with broad analyst coverage, whereas ICHR carries a higher valuation and a more execution-dependent story. Both are high-beta names sensitive to shifts in AI capital-expenditure sentiment.

Tickeron AI Verdict

Weighing observable factors such as trend consistency, stability, catalysts, and relative positioning, Tickeron's AI framework currently leans toward ACMR. The company pairs stronger revenue growth with a record backlog, a net-cash balance sheet, and more visible near-term catalysts, which tend to support more consistent trend characteristics than a turnaround reliant on margin execution. ICHR presents a compelling operational recovery, but its negative free cash flow, higher valuation, and execution-dependent margin story introduce greater variability. This assessment is probabilistic rather than definitive and reflects current data rather than a prediction of future returns.

Exploring Trending AI Robots for Market Insights

In my own research on names like these, I often review Tickeron’s Trending AI Robots to identify which AI-driven strategies are aligned with prevailing conditions. The section highlights bots suited to current market dynamics across various styles and timeframes, helping put relative performance into context without replacing individual due diligence.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: ICHR, ACMR

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


ICHR in -5.82% downward trend, sliding for three consecutive days on November 17, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where ICHR declined for three days, in 251 of 299 cases, the price declined further within the following month. The odds of a continued downward trend are 84%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Aroon Indicator for ICHR entered a downward trend on November 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ICHR's RSI Oscillator exited the oversold zone, 25 of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 78%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 49 of 60 cases where ICHR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.

The Momentum Indicator moved above the 0 level on November 18, 2026. You may want to consider a long position or call options on ICHR as a result. In 59 of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 69%.

The Moving Average Convergence Divergence (MACD) for ICHR just turned positive on November 11, 2026. Looking at past instances where ICHR's MACD turned positive, the stock continued to rise in 35 of 49 cases over the following month. The odds of a continued upward trend are 71%.

Following a +8.71% 3-day Advance, the price is estimated to grow further. Considering data from situations where ICHR advanced for three days, in 251 of 328 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.

ICHR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 13 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.340) is normal, around the industry mean (5.670). P/E Ratio (-26.466) is within average values for comparable stocks, (68.795). Projected Growth (PEG Ratio) (0.251) is also within normal values, averaging (0.801). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (1.761) is also within normal values, averaging (27.897).

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating steady price growth. ICHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ICHR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock worse than average.

Notable companies

The most notable companies in this group are Applied Materials (NASDAQ:AMAT), Lam Research Corp (NASDAQ:LRCX), KLA Corporation (NASDAQ:KLAC), Teradyne (NASDAQ:TER), Ambarella (NASDAQ:AMBA).

Industry description

The electronic production equipment industry makes equipment used to produce semiconductors. Such equipment includes wafer fabrication, plasma etching and photo-resist processing equipment. The industry also makes chemical vapor deposition processing systems and photomasks, which are high-purity quartz plates that contain patterns to define integrated circuits layouts. Applied Materials, Inc., Lam Research Corporation, and KLA-Tencor Corporation are examples of electronic production equipment manufacturing companies.

Market Cap

The average market capitalization across the Electronic Production Equipment Industry is 46.26B. The market cap for tickers in the group ranges from 310.74K to 665.22B. ASMLF holds the highest valuation in this group at 665.22B. The lowest valued company is SMTK at 310.74K.

High and low price notable news

The average weekly price growth across all stocks in the Electronic Production Equipment Industry was -7%. For the same Industry, the average monthly price growth was -20%, and the average quarterly price growth was -41%. ASYS experienced the highest price growth at -1%, while AEHR experienced the biggest fall at -21%.

Volume

The average weekly volume growth across all stocks in the Electronic Production Equipment Industry was 14%. For the same stocks of the Industry, the average monthly volume growth was 24% and the average quarterly volume growth was -35%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 62
P/E Growth Rating: 44
Price Growth Rating: 63
SMR Rating: 71
Profit Risk Rating: 78
Seasonality Score: 27 (-100 ... +100)
AI Screener 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a holding company whose subsidiary manufactures gas and chemical delivery systems for semiconductor process equipment

Industry ElectronicProductionEquipment

Industry
Semiconductors
Address
3185 Laurelview Court
Phone
+1 510 897-5200
Employees
2448
Web
https://www.ichorsystems.com
Interact to see
Advertisement
SDD is an inverse leveraged ETF (exchange-traded fund) built to return roughly -2x the daily move of the S&P SmallCap 600 Index, making it a tactical hedging tool rather than a long-term holding. XXX is an asset-allocation ETF that blends roughly 75% S&P 500 large-cap equities with a 25% sleeve of XRP, a major cryptocurrency, aiming for capital appreciation.
AMD jumped +2.42%, rising $12.81 to $542.95 from Wednesday's close of $530.14, in early regular-session trading Thursday after extending gains built during premarket. The catalyst was Anthropic's IPO, priced at $83 a share above its marketed range and raising $81.3 billion in the largest listing on record; the debut revived sentiment across AI hardware names, and AMD is both an Anthropic supplier and a $2.5 billion investor in the lab.
ROM is an established, leveraged exchange-traded fund (ETF) that targets twice (2x) the daily return of the S&P Technology Select Sector Index, while XXX is a recently launched blended ETF pairing large-cap U.S. equities with XRP exposure. ROM benefits from deep liquidity and roughly $1.1 billion in AUM (assets under management); XXX remains far smaller, with assets measured in the hundreds of thousands of dollars.
NVIDIA (NVDA) has declined roughly 32.6% over the last 30 days, falling from $216.47 on October 20 to around $146 in mid-November trading. The selloff was triggered by the surprise resignation of founder and CEO Jensen Huang, along with governance, regulatory, and China-related concerns.
KLAR dropped -4.84% to $13.75 from Wednesday's close of $14.45, with the decline occurring during Thursday's regular session. JPMorgan downgraded the shares to Hold from Overweight and cut its price target to $17 from $20 in a note published before the open, extending a run of post-earnings target reductions.